European Cardiology Experts

What is recommended for patients with HFrEF to reduce the risk of heart failure hospitalization and death?

When should right heart catheterization be considered in heart failure patients?

Which treatment may be considered for HFmrEF patients to reduce the risk of heart failure hospitalization and death?

In which class of NYHA can Vericiguat be considered for heart failure patients?

What is recommended for patients with HFmrEF to reduce the risk of heart failure hospitalization and death?

Which group of patients may right heart catheterization be considered for in chronic heart failure cases?

Which trial evaluates the effect of Nebivolol intervention on outcomes and rehospitalizations in seniors with heart failure?

What does SGLT2 stand for in the context of cardiovascular trials?

What does PVC represent in the field of cardiology?

Which abbreviation refers to a surgical procedure for patients with aortic valve issues?

What is the full form of QOL when discussing heart-related studies?

In cardiology, what does RVAD typically refer to?

What is an area where HTM needs to prove its worth?

What type of devices can wirelessly provide information on patient physiology?

Which device can detect signs of congestion by monitoring diastolic pulmonary artery pressure?

What is one key advantage of monitoring through implanted devices compared to conventional methods?

Which type of devices are available that only provide a monitoring function?

Based on the text, what is uncertain about wearable technologies for monitoring heart rate and lung congestion?

What is recommended to be assessed at an early follow-up visit 1-2 weeks after discharge for patients with heart failure?

When should long-term treatment with an oral anticoagulant be considered for stroke prevention in patients with atrial fibrillation?

For which type of patients should CCS CABG be considered as the first-choice revascularization strategy?

In LVAD candidates needing coronary revascularization, what should be avoided, if possible?

What should be considered before performing coronary revascularization in patients with heart failure, coronary artery disease, and CCS?

In what circumstances can PCI be considered as an alternative to CABG?

What is the purpose of prognostic stratification in heart failure management?

How can home telemonitoring (HTM) benefit patients with advanced heart failure?

In what clinical scenario is the classification described in Table 14 helpful?

What is a potential advantage of home telemonitoring highlighted during the COVID-19 pandemic?

Why is it important to adjust therapy or seek further advice based on collected clinical parameters?

What role does the indication for durable MCS devices play in heart failure management?

What therapeutic strategy is recommended for patients at high risk of cardiovascular disease to prevent or delay heart failure onset?

Which intervention is recommended for the primary prevention of heart failure in patients with risk factors according to the text?

What therapy is suggested to reduce the risk of heart failure hospitalizations in patients with hypertension?

What lifestyle changes are recommended according to the text for patients with diabetes mellitus to prevent heart failure?

Which specific antimicrobial therapy is recommended for either prevention or treatment according to the text?

What is a key lifestyle change suggested in the text for patients with dyslipidaemia to prevent heart failure?

What does current evidence suggest about routine measurement of BNP or NT-proBNP to guide therapy for HFrEF?

What is a key concept regarding biomarker-supported strategy for HFrEF pharmacotherapy?

What has telemonitoring enabled patients with HF to do remotely?

Why may non-invasive HTM be considered for patients with HF?

What is a key component of education for self-care in patients with HF through telemonitoring?

What level of recommendation is given for non-invasive HTM for patients with HF?